Xencor Inc (XNCR)

Exchange
NASDAQ
Symbol
XNCR
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients and autoimmune diseases in the United States and internationally. The company is headquartered in Monrovia, California.
Country
USA

Stock price

At close: November 5, 2024

  • Open
    21.31
  • High
    21.66
  • Low
    21.01
  • Close
    21.52
  • Volume
    282,332

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
13.76
Payables turnover
4.56
Working capital turnover
0.35
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
26.53
Number of days of payables
80.00
Fixed asset turnover
2.83
Total asset turnover
0.20
 Liquidity ratios
Current ratio
7.36
Quick ratio
7.17
Cash ratio
7.01
Cash conversion cycle
-53.47
 Solvency ratios
Debt-to-assets ratio
0.02
Debt-to-capital ratio
0.02
Debt-to-equity ratio
0.02
Financial leverage ratio
1.42
Interest coverage
-47.53
 Profitability ratios
Gross profit margin
66.04%
Operating profit margin
-74.16%
Pretax margin
-64.34%
Net profit margin
-67.45%
Operating return on assets (Operating ROA)
-14.55%
Return on assets (ROA)
-13.23%
Return on total capital
-20.29%
Return on equity (ROE)
-18.85%